KENGREAL is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Cangrelor.
| Product ID | 10122-620_17ff4f7d-5a56-4086-ad85-09918cce3dd0 |
| NDC | 10122-620 |
| Product Type | Human Prescription Drug |
| Proprietary Name | KENGREAL |
| Generic Name | Cangrelor |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-07-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204958 |
| Labeler Name | Chiesi USA, Inc. |
| Substance Name | CANGRELOR |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | P2Y12 Platelet Inhibitor [EPC],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2015-07-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204958 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-07-08 |
| Marketing Category | NDA |
| Application Number | NDA204958 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-07-08 |
| Ingredient | Strength |
|---|---|
| CANGRELOR | 50 mg/1 |
| SPL SET ID: | 88b434fa-8891-4fd5-9d86-7ea64667c08f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10122-620 | KENGREAL | cangrelor |
| 65293-003 | KENGREAL | cangrelor |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KENGREAL 87442665 not registered Live/Pending |
Chiesi Farmaceutici S.P.A. 2017-05-09 |
![]() KENGREAL 86166110 4867615 Live/Registered |
CHIESI FARMACEUTICI S.P.A. 2014-01-15 |